BioSpace News Archive

Genialis announced it raised more than $13 million in Series A financing to transform the way diseases are diagnosed and treatment decisions are made.

Biomea Fusion, Inc., a clinical-stage biopharmaceutical company dedicated to discovering and developing novel covalent small molecules to treat and improve the lives of patients with genetically defined cancers and metabolic diseases, announced that it has commenced an underwritten public offering of $125.0 million of shares of its common stock.

TELA Bio, Inc today announced its OviTex ® Reinforced Tissue Matrix will be featured in three case reports at the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) conference from March 29 - April 1, 2023, in Montreal, Canada.

BIOXYTRAN, INC. announced that the journal “ Vaccine s ” released a peer-review article, “An Oral Galectin Inhibitor in COVID-19.

HanAll Biopharma Co., Ltd. (KRX: 009420. KS), a global biopharmaceutical company committed to discovering and developing innovative medicines for patients, announced Su-jin Park has been appointed as new Co-Chief Executive Officer.

ACELYRIN, INC. today announced the appointment of Henry Gosebruch to its board of directors.

Lavie Bio Ltd. today is pleased to announce the appointment of Mr. Amit Noam as Chief Executive Officer (“CEO”) of Lavie Bio, effective as of April 16, 2023.

Nevro Corp. today announced that the company will report its financial results for the first quarter ended March 31, 2023 after the market closes on April 26, 2023.

CollPlant Biotechnologies today announced financial results for the full year ended December 31, 2022 and provided a corporate update on its programs.

bluebird bio, Inc. (NASDAQ: BLUE) (“bluebird bio” or the “Company”) today reported financial results and business highlight.